Braun Stacey Associates Inc Merck & Co., Inc. Transaction History

Braun Stacey Associates Inc

  • $2.53 Billion
  • Q1 2024

A detailed history of Braun Stacey Associates Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Braun Stacey Associates Inc holds 221,524 shares of MRK stock, worth $28 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares
221,524
Previous 215,122 2.98%
Holding current value
$28 Million
Previous $23.5 Million 24.64%
% of portfolio
1.16%
Previous 1.08%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024
BUY
$113.24 - $131.95 $724,962 - $844,743
6,402 Added 2.98%
221,524 $29.2 Million
Q4 2023

Jan 23, 2024
SELL
$100.18 - $109.02 $550,589 - $599,173
-5,496 Reduced 2.49%
215,122 $23.5 Million
Q3 2023

Nov 21, 2023
SELL
$102.95 - $114.33 $658,056 - $730,797
-6,392 Reduced 2.82%
220,618 $22.7 Million
Q2 2023

Jul 28, 2023
SELL
$108.61 - $118.38 $24.5 Million - $26.7 Million
-225,656 Reduced 49.85%
227,010 $26.2 Million
Q1 2023

May 08, 2023
BUY
$102.94 - $114.86 $23.3 Million - $26 Million
225,983 Added 99.69%
452,666 $48.2 Million
Q4 2022

Feb 07, 2023
BUY
$87.44 - $112.11 $977,142 - $1.25 Million
11,175 Added 5.19%
226,683 $25.1 Million
Q3 2022

Nov 08, 2022
BUY
$84.53 - $94.96 $1.32 Million - $1.49 Million
15,663 Added 7.84%
215,508 $18.6 Million
Q2 2022

Jul 27, 2022
BUY
$83.49 - $94.64 $3.69 Million - $4.18 Million
44,140 Added 28.35%
199,845 $18.2 Million
Q1 2022

Apr 28, 2022
SELL
$73.51 - $82.4 $1.13 Million - $1.27 Million
-15,430 Reduced 9.02%
155,705 $12.8 Million
Q4 2021

Jan 25, 2022
SELL
$72.28 - $90.54 $5.45 Million - $6.83 Million
-75,419 Reduced 30.59%
171,135 $13.1 Million
Q3 2021

Dec 01, 2021
SELL
$71.68 - $78.83 $12,042 - $13,243
-168 Reduced 0.07%
246,554 $18.5 Million
Q2 2021

Jul 23, 2021
BUY
$70.31 - $77.77 $91,754 - $101,489
1,305 Added 0.53%
246,722 $19.2 Million
Q1 2021

Apr 28, 2021
BUY
$68.86 - $81.11 $430,443 - $507,018
6,251 Added 2.61%
245,417 $18.9 Million
Q4 2020

Feb 03, 2021
BUY
$71.77 - $79.65 $572,796 - $635,686
7,981 Added 3.45%
239,166 $19.6 Million
Q3 2020

Oct 27, 2020
SELL
$73.18 - $82.95 $119,649 - $135,623
-1,635 Reduced 0.7%
231,185 $19.2 Million
Q2 2020

Aug 06, 2020
BUY
$70.42 - $80.13 $95,771 - $108,976
1,360 Added 0.59%
232,820 $18 Million
Q1 2020

Jun 09, 2020
SELL
$63.36 - $87.82 $1.29 Million - $1.79 Million
-20,357 Reduced 8.08%
231,460 $17.8 Million
Q4 2019

Jan 24, 2020
BUY
$77.58 - $87.54 $629,561 - $710,387
8,115 Added 3.33%
251,817 $22.9 Million
Q3 2019

Oct 31, 2019
BUY
$76.08 - $82.93 $197,427 - $215,203
2,595 Added 1.08%
243,702 $20.5 Million
Q2 2019

Jul 25, 2019
SELL
$69.84 - $81.59 $181,234 - $211,726
-2,595 Reduced 1.06%
241,107 $20.2 Million
Q1 2019

Apr 25, 2019
BUY
$69.58 - $79.36 $36,599 - $41,743
526 Added 0.22%
243,702 $20.3 Million
Q4 2018

Jan 28, 2019
SELL
$65.24 - $75.71 $1.71 Million - $1.98 Million
-26,153 Reduced 9.71%
243,176 $18.6 Million
Q3 2018

Oct 29, 2018
SELL
$57.69 - $67.84 $491,403 - $577,861
-8,518 Reduced 3.07%
269,329 $19.1 Million
Q2 2018

Aug 01, 2018
BUY
$50.83 - $59.72 $460,316 - $540,824
9,056 Added 3.37%
277,847 $16.9 Million
Q1 2018

May 01, 2018
SELL
$50.96 - $59.23 $10,956 - $12,734
-215 Reduced 0.08%
268,791 $14.6 Million
Q4 2017

Jan 30, 2018
SELL
$51.62 - $61.64 $1.16 Million - $1.39 Million
-22,555 Reduced 7.74%
269,006 $15.1 Million
Q3 2017

Oct 25, 2017
BUY
$58.67 - $63.13 $17.1 Million - $18.4 Million
291,561
291,561 $18.7 Million

Others Institutions Holding MRK

# of Institutions
3,769
Shares Held
1.87B
Call Options Held
17.3M
Put Options Held
14.8M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $320B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Braun Stacey Associates Inc Portfolio

Follow Braun Stacey Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email